Studying gene expression is now more than simply DNA to RNA to protein. Cellular gene expression relies on not just mRNA but also regulatory RNA, including miRNA and lncRNA. By studying multiple RNA types simultaneously, research can unlock the full picture inside ones sample. miRNA is a key regulator found to be indicated in normal development as well as disease pathology. lncRNA share similarities in length to mRNA, but act as key modulators similar to miRNA.
Join Brian Dugan for a discussion of how simultaneous analysis of coding and noncoding RNAs using QIAGEN’s complete sample-to-insight workflow can reveal the mysteries in your samples.
Brian Dugan, MS, Global Product Manager, QIAGEN
Brian Dugan is the Global Product Manager for QIAGEN’s miRNA business. Previously Brian worked in Genomics with both Personalis in business development and at EdgeBio as a project manager. Prior to that Brian worked at NICHD in molecular genetics and received an MS from Georgetown University in Biochemistry and Molecular Biology.
Who Should Attend?
MicroRNA service providers, CROs, academics, plus –
Researchers in the fields of:
- Biomarker Discovery
- Gene Expression
- MicroRNA Discovery
As the innovative market and technology leader, QIAGEN creates Sample to Insight technologies that enable access to valuable molecular insights from any biological sample. The mission is to make improvements in life possible by enabling our customers to achieve outstanding success and breakthroughs in life sciences, applied testing, pharma, and molecular diagnostics.